International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations.

International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations.
复制标题

DOI:
10.1111/j.1464-5491.2008.02565.x
复制
发表时间:
2008-10
期刊:
Diabetic medicine : a journal of the British Diabetic Association
影响因子:
--
通讯作者:
Colagiuri S
Colagiuri S
中科院分区:
其他
文献类型:
--
作者:
Ceriello A;Colagiuri S

文献摘要

参考文献

被引文献

相似文献

糖尿病是一个重要的和日益增长的问题,全世界有超过2.46亿人患有这种疾病,另有3.08亿人患有葡萄糖耐量受损。根据不同国家的资源,干预措施通常侧重于通过糖化血红蛋白(HbA1c)和空腹血糖(FPG)值评估优化总体血糖控制。然而,越来越多的证据支持控制血糖三联体的所有三个成员,即HbA1c,FPG和餐后血糖(PMG)以改善糖尿病结局的重要性。作为其全球使命的一部分,以促进糖尿病的护理和预防,并找到一种治疗方法,国际糖尿病联合会(IDF)最近制定了一项指南,审查迄今为止的证据PMG和糖尿病并发症的发展。基于对文献的广泛数据库检索,并在包括来自世界各地的专家在内的指导和开发委员会的指导下,IDF餐后血糖管理指南为PMG的适当临床管理提供了建议。这些建议旨在帮助临床医生和组织制定有效管理1型和2型糖尿病患者PMG的策略。以下综述强调了指南的建议、提供的支持证据和得出的主要结论。完整的指南可在http://www.idf.org下载。
Diabetes is a significant and growing concern, with over 246 million people around the world living with the disease and another 308 million with impaired glucose tolerance. Depending on the resources of different nations, intervention has generally focused on optimizing overall glycaemic control as assessed by glycated haemoglobin (HbA1c) and fasting plasma glucose (FPG) values. Nevertheless, increasing evidence supports the importance of controlling all three members of the glucose triad, namely HbA1c, FPG and postmeal glucose (PMG) in order to improve outcome in diabetes. As part of its global mission to promote diabetes care and prevention and to find a cure, the International Diabetes Federation (IDF) recently developed a guideline that reviews evidence to date on PMG and the development of diabetic complications. Based on an extensive database search of the literature, and guided by a Steering and Development Committee including experts from around the world, the IDF Guideline for Management of Postmeal Glucose offers recommendations for appropriate clinical management of PMG. These recommendations are intended to help clinicians and organizations in developing strategies for effective management of PMG in individuals with Type 1 and Type 2 diabetes. The following review highlights the recommendations of the guideline, the supporting evidence provided and the major conclusions drawn. The full guideline is available for download at http://www.idf.org.
DOI: 10.2337/diacare.26.8.2261
发表时间: 2003-08-01
期刊: DIABETES CARE
影响因子: 16.2
作者:
Brand-Miller, J;Hayne, S;Colagiuri, S
通讯作者: Colagiuri, S
DOI: 10.1016/s0195-668x(03)00468-8
发表时间: 2004-01-01
影响因子: 39.3
作者:
Hanefeld, M;Cagatay, M;Rupp, M
通讯作者: Rupp, M
DOI: 10.1001/archinte.161.3.397
发表时间: 2001-02-12
影响因子: --
作者:
Borch-Johnsen, K;Neil, A;Qiao, Q
通讯作者: Qiao, Q
DOI: 10.2337/diabetes.53.3.701
发表时间: 2004-03-01
期刊: DIABETES
影响因子: 7.7
作者:
Ceriello, A;Quagliaro, L;Giugliano, D
通讯作者: Giugliano, D